M4MM
Compass Pathways Schedules Webinar on Psilocybin Therapy Advances for Depression and PTSD
LONDON – Compass Pathways plans to hold a virtual webinar to outline its steps toward launching a psilocybin-based therapy for treatment-resistant depression (TRD) and to share details on upcoming trials for post-traumatic stress disorder (PTSD). ...
Alabama Tightens Hemp Laws, Moves Medical Cannabis Licenses Forward
MONTGOMERY – Alabama regulators ushered in 2026 with a crackdown on unregulated hemp products containing THC, while inching closer to launching a long-delayed medical Cannabis program that could serve thousands of patients by spring. The ...
Week in Review: Cannabis & Psychedelics Industry Highlights
LOS ANGELES – Federal rescheduling under President Trump’s Executive Order sparked widespread state reactions and investor outlooks into early 2026, blending consolidations and expansions with regulatory friction, outright manipulation, and overtures to public opinion. Psychedelics ...
Senate Spending Package Eyes Hemp THC Crackdown as Shutdown Continues, Trump Backs Restrictions
WASHINGTON – A bipartisan spending package drafted to end the nation's longest government shutdown now includes a provision that would sharply curtail sales of hemp-derived THC products, garnering White House endorsement and fierce opposition from ...
Week in Review: Cannabis & Psychedelics Industry Highlights
LOS ANGELES – Operators sharpened their focus on balance sheets and strategic footholds while policymakers grappled with regulatory gaps and emerging threats. Funding flowed into psychedelics innovation, MSOs reported Q3 2025 earnings, trimmed underperformers, and ...
Cronos Group Reports Q3 2025 Financial Results
TORONTO – Cronos Group Inc., a Canadian Cannabis producer with a growing international footprint, reported third-quarter results that marked new highs for revenue, profitability, and cash reserves, even as domestic challenges in Canada tempered some ...
Aurora Cannabis Reports Q2 FY2026 Financial Results
EDMONTON – Aurora Cannabis Inc. posted a solid second quarter for its fiscal 2026, with total net revenue climbing 11% to CA$90.4 million, driven by a surge in international medical Cannabis sales that highlighted the ...
Compass Pathways Schedules Webinar on Psilocybin Therapy Advances for Depression and PTSD
LONDON – Compass Pathways plans to hold a virtual webinar to outline its steps toward launching a psilocybin-based therapy for treatment-resistant depression (TRD) and to share details on upcoming trials for post-traumatic stress disorder (PTSD). ...
Alabama Tightens Hemp Laws, Moves Medical Cannabis Licenses Forward
MONTGOMERY – Alabama regulators ushered in 2026 with a crackdown on unregulated hemp products containing THC, while inching closer to launching a long-delayed medical Cannabis program that could serve thousands of patients by spring. The ...
Week in Review: Cannabis & Psychedelics Industry Highlights
LOS ANGELES – Federal rescheduling under President Trump’s Executive Order sparked widespread state reactions and investor outlooks into early 2026, blending consolidations and expansions with regulatory friction, outright manipulation, and overtures to public opinion. Psychedelics ...
Psyence Biomed Advances Clinical Trials in Psilocybin for Mental Health Treatments
LOS ANGELES- Psyence Biomedical Ltd. a life science biotechnology company focused on natural psychedelics for mental health, has issued updates on its progress in clinical research and corporate development. The company is leading efforts to ...
COMPASS Pathways Receives Analyst Ratings
LOS ANGELES- COMPASS Pathways, a company specializing in mental health treatments, has garnered significant attention in recent market reports due to favorable analyst ratings and its stock performance. Several brokerages have maintained a consensus "Buy" ...
Verano Holdings to Participate in Key Investor Conferences
LOS ANGELES- Verano Holdings Corp. U.S. multi-state cannabis company, has announced its participation in two significant industry conferences. The company’s executives will engage with investors and industry leaders to discuss important market developments and future ...
High Tide Inc. Reports Revenue and Profitability in Q3 2024
LOS ANGELES- High Tide Inc. reported strong financial results for the third fiscal quarter of 2024, with record revenue of $131.7 million, reflecting a 6% increase year-over-year and sequentially. This revenue growth underscores the company's ...
MediPharm Labs Achieves Debt-Free Status with $2.1M Repayment
LOS ANGELES- MediPharm Labs Corp., a pharmaceutical company specializing in cannabis-based health products, has announced the repayment of its remaining $2.1 million convertible debt, making the company materially debt-free. With over $13 million in cash ...
Silo Pharma Advances Regulatory Path for PTSD Treatment SPC-15
LOS ANGELES- Silo Pharma, Inc. a developmental stage biopharmaceutical company, has submitted a proposal for FDA approval of its PTSD treatment, SPC-15, through the 505(b)(2) regulatory pathway. This pathway is designed to shorten clinical timelines ...
Embracing the Evolution: The Rise of Cannabis Consumption Lounges
LOS ANGELES — The cannabis industry is no stranger to innovation, and one of the most promising developments in recent years is the emergence of cannabis consumption lounges. These venues are revolutionizing the way consumers ...
Emerald Cup 2024: Behind the Scenes at a Celebration of Cannabis Culture in Oakland
OAKLAND — Last month, the Emerald Cup 2024, a premier event in the cannabis community, took place at the historic Henry J. Kaiser Convention Center in Oakland. Celebrating its 20th anniversary, this iconic event honors ...
Urbana Breathes New Life into Historic Luka’s Taproom with a New Cannabis Dispensary and Lounge in Oakland
Honoring a Beloved Oakland Landmark, Urbana Introduces a New Paradigm in Cannabis Retail and Consumption OAKLAND, CA – Urbana, one of Northern California’s premier cannabis brands, is thrilled to announce the opening of its newest ...
Michigan Cannabis Sales Hit Record $295.4 Million in August
LOS ANGELES- Michigan's cannabis industry set a new monthly sales record in August, with licensed dispensaries generating $295.4 million in revenue, according to the state's Cannabis Regulatory Agency (CRA). This figure includes $294.1 million from ...
Nixon’s Secret Recordings: A Shift in Private Views on Cannabis
LOS ANGELES- Recently uncovered White House recordings from 1973 reveal that President Richard Nixon privately acknowledged that cannabis was "not particularly dangerous," a stance at odds with his administration's aggressive drug policies. The recordings, discovered ...
FDA Consideration of Psilocybin Therapy Could Impact Millions of Depression Patients
LOS ANGELES- Recent research suggests that the active ingredient in psychedelic mushrooms, psilocybin, may offer significant benefits for individuals struggling with depression, pending approval from the U.S. Food and Drug Administration (FDA). With roughly one ...
California Governor Proposes Emergency Ban on THC in Hemp Products
LOS ANGELES- California Governor Gavin Newsom announced emergency regulations on Friday that would prohibit the sale of hemp products containing detectable levels of THC, the psychoactive compound in cannabis. The move aims to address concerns ...
Medical Cannabis in Germany: A Gateway for Investment and Innovation
The investment climate in Germany's medical cannabis industry is poised for significant expansion, driven by the global cannabis legalization movement, ongoing regulatory changes, and mounting community and market demand. As the country embraces a more ...
MindMed to Present at Key September Investor Conferences
LOS ANGELES- Mind Medicine (MindMed) Inc., a clinical-stage biopharmaceutical company focused on developing novel treatments for brain health disorders, announced its participation in three significant investor conferences in September 2024. MindMed’s management team will engage ...
